Cited by

• Hypothyroidism.

  Evered D, Hall R. Evered D, et al. Br Med J. 1972 Jan 29;1(5795):290-3. doi: 10.1136/bmj.1.5795.290. Br Med J. 1972. PMID: 4550378 Free PMC article. Review. No abstract available.
• Twenty-four hour variations of triiodothyronine (T3) levels in patients who had thyroid ablation for thyroid cancer, receiving T3 as suppressive treatment.

  Busnardo B, Girelli ME, Bui F, Zanatta GP, Cimitan M. Busnardo B, et al. J Endocrinol Invest. 1980 Oct-Dec;3(4):353-6. doi: 10.1007/BF03349370. J Endocrinol Invest. 1980. PMID: 6782151
• Effects of a single high oral dose of thyroxine on the pituitary-thyroid-axis.

  Hoff HG, Hackenberg K, Reinwein D. Hoff HG, et al. J Endocrinol Invest. 1981 Jan-Mar;4(1):45-8. doi: 10.1007/BF03349413. J Endocrinol Invest. 1981. PMID: 6787109
• Treatment of hypothyroidism: a reappraisal of thyroxine therapy.

  Evered D, Young ET, Ormston BJ, Menzies R, Smith PA, Hall R. Evered D, et al. Br Med J. 1973 Jul 21;3(5872):131-4. doi: 10.1136/bmj.3.5872.131. Br Med J. 1973. PMID: 4720761 Free PMC article.
• Thyrotrophin augmentation after commencing thyroxine replacement in primary hypothyroidism.

  Ghose RR, Upadhyay HP. Ghose RR, et al. Postgrad Med J. 1986 Jan;62(723):11-4. doi: 10.1136/pgmj.62.723.11. Postgrad Med J. 1986. PMID: 3797360 Free PMC article.